CIK: 1271123 - Address: C/O Acurx Pharmaceuticals, Inc.,, 259 Liberty Avenue, Staten Island, NY 10305
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret111-3-23-30-13-210-18
P%wins0000010017

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/4/24 16:24
1/3/24
ACXPAcurx Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsLuci David PNYDOTP,CEOM.d703.5502021,098D
7/29/22 17:01
7/27/22
ACXPAcurx Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsLuci David PNYDOTP,CEOP.d753.8002021,079D
11/22/21 16:05
11/19/21
ACXPAcurx Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsLuci David PNYDOTP,CEOP254.800501,059D
3/19/14 12:20
3/18/14
DPRXDipexium Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsLuci David PDOTP,CEO,SeP.d2512.006201,837D-8-3-23-30-13-210
1/4/08 08:48
12/31/07
MACMMacrochem CorpDEHealthDrugPharmaceutical PreparationsLuci David POVPP20.590003745D
4/5/06 16:33
4/3/06
BIVNBioenvision IncDEHealthDrugPharmaceutical PreparationsLuci David PNYOCFO,Gen.M.d810.7350011065279
3/7/06 16:25
3/6/06
BIVBioenvision IncDEHealthDrugPharmaceutical PreparationsLuci David PNYOCFO,Gen.S-1,0757.960-135-44169
3/2/06 11:39
2/28/06
BIVBioenvision IncDEHealthDrugPharmaceutical PreparationsLuci David PNYOCFO,Gen.S-5578.570-65-18304
6/24/04 10:53
6/22/04
BIVBioenvision IncDEHealthDrugPharmaceutical PreparationsLuci David PNYOSee ExhiP88.2501148D
11/25/03 13:37
11/19/03
BIVBioenvision IncDEHealthDrugPharmaceutical PreparationsLuci David PNYOSee ExhiP243.4007New7D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact